(Q85006289)
Statements
Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2/3 clinical trial (English)
Atsuyuki Igarashi
Takeshi Kato
Mai Kato
Michael Song
Hidemi Nakagawa
Japanese Ustekinumab Study Group
29 September 2011